KEQU (STOCKS)
Kewaunee Scientific Corp
$34.690000
+0.420000 (+1.23%)
Prev close: $34.270000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Thomas D. Hull
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $99.43M
- Employees
- 1,239
- P/E (TTM)
- 9.32
- P/B (TTM)
- 1.41
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2026 (Q3)
|
$0.28 | $0.00 | +0.0000 | +0.00% |
|
Jun 2026 (Q2)
|
$0.91 | $0.00 | +0.0000 | +0.00% |
|
Mar 2026 (Q1)
|
$1.10 | $0.00 | +0.0000 | +0.00% |
|
Dec 2025 (Q4)
|
$1.95 | $0.00 | +0.0000 | +0.00% |
Financial Statements
| Revenues | $287.75M |
| Benefits Costs and Expenses | $271.62M |
| Cost Of Revenue | $204.51M |
| Costs And Expenses | $271.62M |
| Gross Profit | $83.23M |
| Operating Expenses | $63.23M |
| Operating Income/Loss | $20.00M |
| Income/Loss From Continuing Operations After Tax | $11.72M |
| Income/Loss From Continuing Operations Before Tax | $16.13M |
| Income Tax Expense/Benefit | $4.41M |
| Net Income/Loss | $11.72M |
| Net Income/Loss Attributable To Noncontrolling Interest | $640.00K |
| Net Income/Loss Attributable To Parent | $11.08M |
| Net Income/Loss Available To Common Stockholders, Basic | $11.08M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $3.87 |
| Diluted Earnings Per Share | $3.72 |
| Basic Average Shares | 5,723,000 |
| Diluted Average Shares | 5,960,000 |
| Assets | $175.96M |
| Current Assets | $103.58M |
| Inventory | $32.91M |
| Other Current Assets | $70.67M |
| Noncurrent Assets | $72.38M |
| Fixed Assets | $22.61M |
| Intangible Assets | $16.68M |
| Other Non-current Assets | $33.09M |
| Liabilities | $103.43M |
| Current Liabilities | $48.79M |
| Accounts Payable | $23.64M |
| Wages | $7.32M |
| Other Current Liabilities | $17.83M |
| Noncurrent Liabilities | $54.65M |
| Long-term Debt | $21.33M |
| Other Non-current Liabilities | $33.32M |
| Equity | $72.53M |
| Equity Attributable To Noncontrolling Interest | $1.85M |
| Equity Attributable To Parent | $70.68M |
| Liabilities And Equity | $175.96M |
| Net Cash Flow From Operating Activities | $22.58M |
| Net Cash Flow From Operating Activities, Continuing | $22.58M |
| Net Cash Flow From Investing Activities | -$3.53M |
| Net Cash Flow From Investing Activities, Continuing | -$3.53M |
| Net Cash Flow From Financing Activities | -$20.71M |
| Net Cash Flow From Financing Activities, Continuing | -$20.71M |
| Exchange Gains/Losses | -$329.00K |
| Net Cash Flow | -$1.99M |
| Net Cash Flow, Continuing | -$1.66M |
| Comprehensive Income/Loss | $10.79M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $640.00K |
| Comprehensive Income/Loss Attributable To Parent | $10.15M |
| Other Comprehensive Income/Loss | -$931.00K |